Li, S., Zhu, C., Zhou, X., Chen, L., Bo, X., Shen, Y., . . . Yue, W. (2022). Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley.
シカゴスタイル引用形Li, Shaoyue, et al. Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley, 2022.
MLA引用形式Li, Shaoyue, et al. Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley, 2022.
警告: この引用は必ずしも正確ではありません.